Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 * | 90.47M 113M | Sales 2024 * | 130M 162M | Capitalization | 219M 273M |
---|---|---|---|---|---|
Net income 2023 * | -89M -111M | Net income 2024 * | -38M -47.46M | EV / Sales 2023 * | 1.87 x |
Net cash position 2023 * | 49.23M 61.48M | Net cash position 2024 * | 15.5M 19.36M | EV / Sales 2024 * | 1.56 x |
P/E ratio 2023 * |
-2.4
x | P/E ratio 2024 * |
-5.68
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
-3.04% | 104B | |
+0.69% | 97.42B | |
+0.79% | 22.2B | |
-18.00% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.64% | 15.06B | |
+4.28% | 13.98B | |
+30.66% | 11.66B |